Advertisement
UK markets close in 1 hour 38 minutes

  • FTSE 100

    8,123.87
    +45.01 (+0.56%)
     

  • FTSE 250

    19,783.48
    +181.50 (+0.93%)
     

  • AIM

    755.25
    +2.13 (+0.28%)
     

  • GBP/EUR

    1.1671
    +0.0014 (+0.12%)
     

  • GBP/USD

    1.2510
    -0.0001 (-0.01%)
     

  • Bitcoin GBP

    51,503.34
    +810.32 (+1.60%)
     

  • CMC Crypto 200

    1,329.09
    -67.45 (-4.83%)
     

  • S&P 500

    5,094.69
    +46.27 (+0.92%)
     

  • DOW

    38,223.56
    +137.76 (+0.36%)
     

  • CRUDE OIL

    84.04
    +0.47 (+0.56%)
     

  • GOLD FUTURES

    2,351.80
    +9.30 (+0.40%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,092.88
    +175.60 (+0.98%)
     

  • CAC 40

    8,070.99
    +54.34 (+0.68%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Shire to roadshow benchmark US dollar bond Sept 12-15: Source

Reuters - UK Focus

By Hillary Flynn

NEW YORK, Sept 7 (IFR) - Drugmaker Shire Plc will start marketing a benchmark US dollar bond early next week, according to a note sent to investors seen by IFR.

Bank of America Merrill Lynch, Barclays (LSE: BARC.L - news) and Morgan Stanley (Xetra: 885836 - news) are arranging the fixed-income investor meetings, which will be held in the US and London between September 12-15, according to the note.

Bank of America (Swiss: BAC.SW - news) is acting as logistics coordinator on the roadshow.

Shire (Xetra: S7E.DE - news) announced earlier this year that it had agreed to buy Baxalta International Inc in a US$32bn cash and stock offer. (Reporting by Hillary Flynn; Editing by Paul Kilby and Shankar Ramakrishnan)